来源：市场资讯 （来源：智超讲财商） 当前，我国优质中小企业梯度培育工作正稳步推进，政策春风持续吹拂中小企业发展沃土。从高质量编制"十五五"促进中小企业发展规划，到 加快研究构建专精特新中小企业发展壮大机制，一系列靶向施策的举措陆续出台。同时，专精特新赋能中心的探索建设，正推动创新链与产业 链精准对接，为中小企业高质量发展注入强劲动力。 在这一发展浪潮中，专精特新"小巨人"企业无疑是最耀眼的核心力量。作为优质中小企业的标杆，它们深耕产业基础核心领域，扎根产业链关 键环节，以专注铸专长、以创新强内核，成为细分市场的"隐形冠军"，为我国产业体系的韧性与活力提供了坚实支撑。 这些"小巨人"企业的发展能级，不仅是自身竞争力的体现，更成为观察区域先进制造业创新力与发展水平的重要窗口。在产业"雨林生态"中， 它们既引领着中小企业成长方向，更以点带面激活产业集群效应，书写着我国制造业转型升级的生动篇章。 其中，截至11月20日，2025年共有50家国家级专精特新"小巨人"企业首发上市，占年内A股IPO数量的52.63%。 国家级专精特新"小巨人" 2023年以来，截至11月20日，有508家企业在A股首发上市，IPO募资额 ...

Group 1 - The company, China Resources Materials, stated that as of November 20, 2025, the number of shareholders (including credit accounts) is expected to reach 23,116 [1]

Core Viewpoint - Kasei Biotech's wholly-owned subsidiary, Anhui Hexian, is focused on the research, production, and sales of bio-based polyamide modified resins, with applications in various sectors including automotive piping, passenger vehicle interiors and exteriors, low-voltage electrical appliances, and composite materials. The facility is currently in the equipment installation and debugging phase and has not yet commenced production [1]. Group 1 - Anhui Hexian is a wholly-owned subsidiary of Kasei Biotech [1] - The company specializes in bio-based polyamide modified resins [1] - Applications for the products include automotive piping and passenger vehicle interiors and exteriors [1] Group 2 - The facility is currently in the installation and debugging phase [1] - Production has not yet started [1]

上纬新材公告称，2025年7月9日至11月24日，公司股价累计上涨1373.78%，多次触及异常波动及严重 异常波动情形。近期开展的具身智能机器人业务处于产品开发阶段，未形成营收及利润，预计对2025年 业绩无正向影响。公司于11月25日完成董事会换届，新管理团队就位。收购方未来12个月无资产重组计 划，36个月内无借壳上市安排。目前公司基本面未变，但股价脱离基本面，外部流通盘小、市盈率高， 存在炒作和下跌风险，提醒投资者注意。 ...

Group 1 - The company, Xinzhou Bang, stated that its electrolyte business follows market-based pricing principles, similar to its peers [2] - For long-term contracts, the company will actively promote price transmission based on market conditions while adhering to agreements with customers [2] - The rising prices of raw materials, represented by lithium hexafluorophosphate, are gradually being reflected in the pricing of electrolytes, with the fourth quarter currently in a price transition phase [2] Group 2 - The company will fully reference the latest raw material market prices for pricing new contracts, indicating an improvement in price transmission efficiency [2]

（文章来源：证券日报） 证券日报网讯达威股份11月25日在互动平台回答投资者提问时表示，二级市场股价受资本市场情绪、轮 动及短期流动性等多因素综合影响，请注意投资风险。公司高度重视市值管理，并将继续优化资本运作 策略，在确保稳健生产经营的同时，积极传递公司的长期价值，推动生产经营与市值管理双轮驱动，实 现股东利益最大化。 ...

Core Viewpoint - JinDan Technology is actively extending its main business into the upstream and downstream of the industry chain while maintaining stable development in the production, operation, and management of lactic acid and its derivatives [2] Group 1: Business Strategy - The company is focusing on market trends and external environmental changes to enhance its core business [2] - JinDan Technology is implementing a vertically integrated circular industrial chain that includes the production, sales, and research of products such as corn, starch, by-products, lactic acid, lactic salts, esters, polylactic acid, and PBAT [2] Group 2: Future Outlook - The company plans to continue its development through technology introduction and collaborative development [2] - Investors are encouraged to pay attention to the company's subsequent announcements and periodic reports for further updates [2]

Investment Rating - The investment rating for the company is "Buy" and is maintained [6]. Core Insights - The company reported a revenue of 842 million yuan for Q3 2025, representing a year-on-year increase of 48.9%. The net profit attributable to shareholders was 31 million yuan, with a non-recurring net profit of 11 million yuan. For Q3 2025 alone, revenue reached 332 million yuan, up 62.41% year-on-year and 24.33% quarter-on-quarter, with significant improvements in profitability [2][4]. Financial Performance Summary - For the first three quarters of 2025, the company achieved a total revenue of 842 million yuan, a 48.9% increase compared to the previous year. The net profit attributable to shareholders was 31 million yuan, while the non-recurring net profit stood at 11 million yuan. In Q3 2025, the company recorded a revenue of 332 million yuan, marking a year-on-year growth of 62.41% and a quarter-on-quarter increase of 24.33%. Both net profit and non-recurring net profit showed substantial recovery compared to previous periods [2][4][11]. Future Outlook - The company is expected to see further increases in sales of its negative electrode coating agents, particularly in high-temperature products. The improvement in product structure and rising prices of by-products are anticipated to enhance revenue. The overall profitability is projected to continue its upward trend, supported by high capacity utilization and a favorable order outlook for Q4 2024. The company’s carbon fiber business is also progressing, potentially opening a second growth curve [11].

Group 1 - The company plans to reduce its holdings by up to 4.8511 million shares, accounting for 1.35% of the total share capital, from November 24, 2025, to May 23, 2026 [1] - On November 25, 2025, the company has already reduced its holdings by 300,000 shares, which is 0.0835% of the total shares, with a transaction amount of 1.807 million yuan [1] - The highest price during the transaction was 6.04 yuan per share, the lowest was 6 yuan per share, and the average price was 6.02 yuan per share [1]

Group 1 - The core viewpoint of the article highlights that the demand for lithium-ion batteries is currently strong, leading to an increase in the prices of certain raw materials and battery materials [2] - The company,瑞泰新材, has a current production capacity of over 2000 tons for lithium-ion battery electrolyte additives, including LiTFSI, which is sufficient to meet market demand [2] - The company acknowledges that the solid-state battery technology still requires development in technical, product, and commercial aspects, urging investors to be cautious about investment risks [2]